You Searched For "zepbound" and got 20 results
Sort By:
3 mins read
Weight loss and diabetes drug Tirzepatide will cost Rs 80,000 per month in India
Tirzepatide is set to make its debut in the Indian market under the brand name Mounjaro for the tre…
1 min read
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030, Goldman Sachs says
The anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs analysts said in a r…
George Glover
2 mins read
Another perk of weight-loss drugs? Eli Lilly's Zepbound may alleviate sleep apnea, too
The new class of weight-loss drugs isn't just for diabetes and weight loss. Eli Lilly results from …
Hilary Brueck
2 mins read
Eli Lilly soars 8% after Q1 earnings reveal surging popularity for its Zepbound weight-loss drug
"Demand continues to outstrip even increased supply," Eli Lilly's CFO said of its Zepbound weight l…
Matthew Fox
3 mins read
People lost nearly 50 pounds on Zepbound — but gained more than half back when they stopped taking it
Zepbound can help people lose significant amounts of weight, but may need to be taken long-term to …
Gabby Landsverk
2 mins read
Eli Lilly just halved the price of its weight-loss drug — declaring war on the booming market of knock-offs
Eli Lilly is now offering cheaper single-dose vials of its wildly popular weight-loss drug Zepbound…
Gabby Landsverk
2 mins read
Eli Lilly's weight-loss drug may prevent diabetes — but there's 1 unanswered question
People with pre-diabetes who took Zepbound or Mounjaro were 94% less likely to develop the disease,…
Hilary Brueck
1 min read
'Unbelievable demand' for weight-loss drugs sends Eli Lilly stock soaring 14% after earnings
"We just see unbelievable demand, and we're not even trying that hard to promote this drug. We're n…
Matthew Fox
2 mins read
The next big market for weight-loss drugs: children
Novo Nordisk's weight loss drug, Saxenda, helped children ages six to 11 reduce their body mass ind…
Shubhangi Goel
2 mins read
A man rapidly lost weight on a popular weight-loss drug. After 6 months, he was hospitalized with heart problems and confusion.
A man lost more than 80 pounds in six months on popular weight drug tirzepatide. He hadn't adjusted…
Gabby Landsverk
3 mins read
Kourtney Kardashian just launched her own take on Ozempic
Kourtney Kardashian's new supplement, Lemme GLP-1 Daily, is marketed as a natural alternative to Oz…
Kim Schewitz
2 mins read
People who use weight loss drugs like Ozempic face a problem: What to do when they run out or can't take them anymore
Patients sometimes have to stop using GLP-1 medications like Ozempic and Wegovy and risk regaining …
Alex Bitter
3 mins read
A millennial couldn't afford the Mounjaro weight-loss drug so he started secretly working 2 remote jobs. He's on track to make $166,000 this year and says he's lost 45 pounds.
A California-based millennial started secretly working two remote jobs to pay for Mounjaro weight-l…
Jacob Zinkula
1 min read
A new Ozempic rival helps patients lose fat, but keep their muscle the holy grail for a weight-loss drug
The Ozempic rival helped people lose weight while keeping more of their muscles intact. In a trial,…
Hilary Brueck
2 mins read
Google's new CFO Anat Ashkenazi raked in a nearly $10 million signing bonus
Alphabet announced Wednesday that Anat Ashkenazi, who worked at Eli Lilly since 2001, will be the c…
Katherine Tangalakis-Lippert
3 mins read
Eli Lilly rides the weight-loss-drug wave to a new record high, and is now worth more than $700 billion
"We haven't scratched the surface in terms of how big the [GLP-1 weight loss] drugs are going to ge…
Matthew Fox
2 mins read
Viking Therapeutics' weight loss drug showed faster results in clinical trials than Ozempic or Wegovy. Here's how it works.
Viking Therapeutics' experimental drug helped patients lose weight faster than other popular GLP-1 …
Gabby Landsverk
2 mins read
Eli Lilly stock will surge 29% over the next year with its weight-loss drug on pace to do $60 billion in sales by 2030, BofA says
"We'd argue our forecasts are still conservative, as by 2030, we assume <7% of US adults will be…
Matthew Fox
2 mins read
Blockbuster weight-loss drug Wegovy's sales just doubled and could heat up even more with a price cut
Sales of Wegovy more than doubled in the first quarter year on year to $1.3 billion.
Shubhangi Goel
4 mins read
Weight-loss drugs just got cheaper and better
Eli Lilly priced its new weight-loss drug Zepbound 20% lower than competitor Wegovy, an unusual mov…